Advancing Medical & Pharmaceutical Innovation
Our W2G Nursery uses top-of-the-line tissue culture micropropagation breeding equipment that creates disease-free plants and increases plant yield. We are able to customize unique medical-grade strains of cannabis cultivars and psilocybin spores in a completely sterile production environment while reducing disease, pests, and pathogens.
Identifying new bioactive compounds to determine interactions with specific genes responsible for chronic conditions. Future research will examine the potential application for cannabis and psilocybin to help reduce specific chronic conditions or diseases.
W2G's extensive research and IP approach is focused on the development of several new plant based cultivation techniques, hybrid strain development, genetic profiling & tissue culture. We have developed a consistent phytopharmaceutical feedstock growth-plan through the use of tissue culture and molecular biology.
Our new technology and process allows us to rapidly clone cannabis cultivars and psilocybin spores with desirable traits and elite genetics.
These methods developed allow for the standardization of the procedures used to ensure high quality and consistent biopharmaceuticals.